The Mission To Protect The Youth Against Melanoma

February 19 21:50 2016

Dr. Aleksandr Itkin, a dermatologist and President of GeneImpact Inc., has made it a personal mission to prevent skin cancer among children, having been diagnosed with melanoma himself at the age of 28.
Skin cancer, particularly melanoma, is a growing health concern.

For over a span of 4 decades since the 1970s, there has been an 800 percent increase in the incidence of melanoma among young American women and 400 percent of young men. Additionally, approximately 1 person dies of melanoma every 57 minutes. However, not everything is bad news. With recent advances in the understanding of disease causation and treatment technology, the melanoma survival rates are now greater than 92 percent compared to 49 percent in the 1950s. However, melanoma treatment is not cheap. Melanoma treatment in the United States accounts for $3.3 billion every year with an additional $2.85 billion in work productivity losses, while the total expenses for treatment of all types of skin cancer stand at $8.1 billion annually. It is clear that melanoma can be treated but at a hefty price tag.

There should be an effective way of preventing melanoma and non-melanoma skin cancer right at the very start. This will significantly reduce the costs of treating skin cancers and melanoma as well as the financial costs of work productivity losses.

Around 86 percent of all melanoma cases and almost 100% of non-melanoma skin cancers are attributed to prolonged exposure to the sun’s ultraviolet radiation. And as individuals continually get exposed to the sun, the growing percentage of UV exposure gradually increases over a span of 80 years. In the management of melanoma and non-melanoma skin cancer, prevention must, therefore, be geared towards the under-18 age bracket of the population where they are expected to account for an average accumulated UV exposure of 22.73 percent.

Dr. Aleksandr Itkin, a dermatologist and President of GeneImpact Inc., has made it a personal mission to prevent skin cancer among children, having been diagnosed with melanoma himself at the age of 28. GeneImpact Inc., is partnering up with Sunscreen Mist, a company who’s patented sunscreen application system, is considered convenient and effective in addition to being simple to use. GeneImpact Inc. has an exclusive distribution right for California, Arizona and Nevada K-12 schools, but that may expand to all the US Southern belt states. For educational institutions, the Sunscreen Mist system is inexpensive, low maintenance, highly customizable, and very durable to make a significant investment in safeguarding the health of all pupils and students against melanoma and non-melanoma skin cancers.

Sunscreen Mist system comes with two solutions – the dual spray station and the booth system. Both systems contain FDA-approved sunscreen lotion mist that is rated at SPF 50, hypoallergenic, water resistant, and fragrance-free. Additionally, the aloe vera and water-based formulation do not carry chemicals like nanoparticles, parabens, and oxybenzone. The Sunscreen Mist systems can be conveniently operated with a swipe of the student’s or the teacher’s ID cards and expected to deliver the correct amounts of sunscreen lotion within 5 to 10 seconds. An excellent fixture in dressing rooms, stadiums, swimming pools, football fields, and school playgrounds, the Sunscreen Mist is a welcome service by institutions to their students and pupils.

Dr. Itkin believes that with GeneImpact Inc. and Sunscreen Mist system, combining forces, will combat genetic damage to skin, in-turn the younger generation will have a greater chance of preventing melanoma in their lifetime. For schools and parents, this will be a very significant development in their children’s young lives.

Distributed by GeneImpact Inc.

Media Contact
Company Name: GeneImpact Inc.
Contact Person: Dr. Aleksandr Itkin
Email: [email protected]
Phone: 4455 Morena Blvd., Ste 201
City: San Diego
State: CA
Country: United States